2017 Pilot & Feasibility Application


Expression of Intent due August 1, 2017.

Full application due Friday, September 1, 2017 (see"Submitting an Application")

Amount of funding/Budget Information:

Applicants may request up to $50,000 in direct costs for one or two year duration of the administrative supplements under this program.

Most Pilot and Feasibility Projects will be a one-year project and continuation of a project beyond its first year will be contingent upon the success of the previous year.

Start date: December 1, 2017

Purpose and Request for Applications

The Diabetes Research Center (Stanford DRC) is soliciting new Pilot and Feasibility Projects.  The focus of the Stanford DRC Pilot and Feasibility Program is to provide seed funds to help develop new investigators as well as support innovative and/or high-risk proposals from more senior investigators involved in any aspect of diabetes related research, including but not limited to basic sciences, economics, population sciences, translational research and clinical research.

The approved Pilot and Feasibility Project proposals will assist current and future applications to the NIH/NIDDK to support the Stanford Diabetes Research Center and this P&F program. However, institutional funds have been made available to support 5-10 projects. 


Any Stanford or VA investigator with an M.D., a Ph.D., or both degrees is eligible. The applicant must have at least two years of full-time laboratory/clinical research experience after receiving the advanced degree. PI status or a PI Waiver is required. Applications from established investigators new to diabetes research are also encouraged.

Preference will be given to:

1) younger investigators (e.g. advanced postdoctoral fellow or instructor with a sponsor or an Assistant Professor) who have a high potential for extramural funding in the near future and to become independent investigators;

2) applications that focus on translational studies of diabetes prevention and control; and

3) applications that involve a collaborative component between the laboratories of Stanford investigators.

Submitting an Application

Expression of Intent: Deadline August 1, 2017

A brief EOI is required, and due by midnight, August 1st. This EOI can be transmitted by email. The EOI should include the PI’s name, list of participating investigators, a non-binding proposal title, and 2-4 sentence description of the proposal. This will be used to facilitate review of the proposals.

Application Deadline: Friday, September 1, 2017

Applicants should submit one electronic copy of the following as an e-mail attachment to Dr. Kraemer at fbk@stanford.edu

1.   Title page with the following information:

  • Project title
  • project leader's name, title, department, complete contact information (Faculty Sponsor's name if the project leader is an advanced postdoctoral fellow or instructor)
  • co-investigators: names, titles, department affiliation, complete contact information

2.    5 page description of proposed research, including the following:

  • research plan
  • description of research subjects involved (both human or animal)
  • description of interdisciplinary characteristics of this project as it utilizes Specialized Resources (the DRC is expected to have an OMICs/Bioinformatics/Statistics Core, an Immune Monitoring Core, and an Islet Cell Core)
  • explanation of how the proposed research fits into Diabetes related research (note: illustrations and references are not included in the 5 page limit)

3.  Detailed budget for up to $50,000 excluding F&A costs.

4.  Budget justification

5.  Biosketch (NIH format) for the Project Leader and Co-Investigators

6.  Other Support (also NIH format). Please include both active and pending support.

7.  Agreement to provide progress reports and required presentations on P&F Project Progress to the SDRC.

The Stanford DRC Executive Committee will review and recommend action on all Pilot and Feasibility Project applications.



Applicants are welcome to discuss their plans in response to this solicitation. Please direct these inquiries to Dr. Fredric Kraemer at fbk@stanford.edu or Dr. David Maahs at dmaahs@stanford.edu